Unlocking therapies for hard-to-treat lung cancers

July 24, 2019
Around 85 percent of lung cancers are classified as non-small-cell lung cancers, or NSCLCs. Some patients with these cancers can be treated with targeted genetic therapies, and some benefit from immunotherapies -- but the vast majority of NSCLC patients have no treatment options except for chemotherapy. Read more
Reading level: Grade 9
EurekAlert!, the online, global news service operated by AAAS, the science society
Please Give Us Feedback!

Why are you reading this article? (check all that apply)







How do you feel about science?







Send Feedback